Addex Therapeutics Ltd ADR (ADXN) Stock Price, Quote & News

Company Profile

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, which is in phase 1 for undisclosed indication;...

Industry: Biotechnology

Sector: Healthcare

Phone: 41 22 884 1555

Fax: 41 22 884 1556

Website: www.addextherapeutics.com

Address:

Chemin des Mines, 9, Geneva, Switzerland

EarningsInsider Jun. 25 at 3:02 PM

https://www.marketbeat.com/earnings/reports/2026-6-25-addex-therapeutics-ltd-stock/ $ADXN Addex Therapeutics Earnings Transcript

0 · Reply

flybyme Jun. 25 at 11:26 AM

$ADXN So after these great results , can we expect the pumpers to return, did not think so.

0 · Reply

flybyme Jun. 25 at 11:25 AM

$ADXN https://www.addextherapeutics.com/en/investors/press-releases/addex-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update/

0 · Reply

Merlintrader Jun. 22 at 10:55 AM

$ADXN $DFTX / $MLTX / $CVM — From the Biotech World Today: Four Smaller Headlines Worth Watching https://www.merlintrader.com/biotech-world-smaller-headlines-jun22/

1 · Reply

focafoca99 Jun. 22 at 5:13 AM

$ADXN will report its Q1 2026 results on June 25 and host a conference call.

0 · Reply

NVDAMillionaire Jun. 10 at 11:36 AM

$ADXN Brilliant piece that captures ADXN's situation perfectly. So if you want to update your understanding of ADXN or get to know ADXN better, this is essential reading. https://everyticker.com/quote/ADXN/analysis/addex-therapeutics-a-9-million-option-ticket-on-neurosterix-s-success-nasdaq-adxn

0 · Reply

flybyme Jun. 4 at 4:40 PM

$ADXN `as we zzzzzzzzzzz on , where are all the pumpers?

0 · Reply

BioRich May. 20 at 7:08 AM

$RXRX $CAI $VRDN $ADXN $ANVS (Sorry, using this is a placeholder to see how these track over time. Posting late so as to not clog the boards or appear as spam.)

1 · Reply

StocktwitsEarnings Apr. 30 at 12:00 PM

$ADXN Q2 '25 Earnings Results & Recap Addex Therapeutics reported a net loss of CHF6.7M for 2025, compared to a net profit of CHF7.1M in 2024, with basic and diluted loss per share at CHF 0.06. Cash position was CHF1.6M.

0 · Reply

flybyme Apr. 21 at 6:39 PM

$ADXN https://www.addextherapeutics.com/en/investors/press-releases/addex-gabab-pam-candidate-demonstrates-robust-anti-tussive-activity-non-human-primate-chronic-cough-model/

0 · Reply

Addex Therapeutics Earnings Call Transcript: Q1 2026

Jun 25, 2026, 10:00 AM EDT - 9 days ago

Addex Therapeutics Quarterly report: Q1 2026

Jun 25, 2026, 10:00 AM EDT - 9 days ago

Addex Therapeutics Earnings release: Q1 2026

2026-06-25T10:30:56.000Z - 9 days ago

Addex Therapeutics Releases Q1 2026 Financial Results

2026-06-25T06:11:40.000Z - 9 days ago

Addex Records Wider Net Loss Of $1.7 Mln; Advances NTX-253 In Phase 1 For Schizophrenia

Thu, 25 Jun 2026 01:00:00 -0400 - 9 days ago

Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Mon, 22 Jun 2026 01:00:00 -0400 - 12 days ago